Alejandra
Otero Ferreiro
Clínica Universitaria de Navarra
Pamplona, EspañaPublications in collaboration with researchers from Clínica Universitaria de Navarra (6)
2024
2022
-
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss
American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181
2017
-
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Transplant International, Vol. 30, Núm. 10, pp. 1041-1050
2011
-
Cyclosporine A-based immunosuppression reduces relapse rate after antiviral therapy in transplanted patients with hepatitis C virus infection: A large multicenter cohort study
Transplantation, Vol. 92, Núm. 3, pp. 334-340
2009
-
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids
Liver Transplantation, Vol. 15, Núm. 11, pp. 1542-1552
2007
-
Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study
Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2311-2313